Healthy Living/WellnessCRISPR/Cas Firm Intellia Files IPO, Announces $125 Million Deal With Regeneron CRISPR firm Intellia Therapeutics filed an IPO and announced its collaboration with biopharmaceutical company Regeneron. The deal between the two companies aims to develop CRISPR/Cas technology and commercialize targets along the way.by Rina Marie Doctor
Healthy Living/WellnessNew Study Links Hormone Therapy For Prostate Cancer To Depressionby Ted Ranosa
Healthy Living/WellnessChinese Scientists Edit Genes Of Human Embryos For The Second Timeby Katrina Pascual
Healthy Living/WellnessGenetic Superheroes: Scientists Find 13 Rare Individuals Resistant To Hereditary Diseasesby Rhodi Lee
Healthy Living/WellnessDARPA Wants Shape-Shifting Vaccines That Adapt Real-Time When Fighting Killer Viruses: Here's The Planby Milafel Dacanay
Healthy Living/WellnessFitbit Tracker Likely Saved This Man's Life, Leading Doctors To Shock His Heart Back To Normalby Alexandra Burlacu
10 Hidden Android Tricks and Settings Tips in Android 2025 That Instantly Boost Your Phone Experience